BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 28703703)

  • 1. Estimating multimorbidity prevalence with the Canadian Chronic Disease Surveillance System.
    Feely A; Lix LM; Reimer K
    Health Promot Chronic Dis Prev Can; 2017 Jul; 37(7):215-222. PubMed ID: 28703703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimating chronic disease rates in Canada: which population-wide denominator to use?
    Ellison J; Nagamuthu C; Vanderloo S; McRae B; Waters C
    Health Promot Chronic Dis Prev Can; 2016 Oct; 36(10):224-230. PubMed ID: 27768559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multimorbidity prevalence in Canada: a comparison of Northern Territories with Provinces, 2013/14.
    Basham CA; Karim ME
    Int J Circumpolar Health; 2019 Dec; 78(1):1607703. PubMed ID: 31043136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in chronic disease incidence rates from the Canadian Chronic Disease Surveillance System.
    Hamm NC; Pelletier L; Ellison J; Tennenhouse L; Reimer K; Paterson JM; Puchtinger R; Bartholomew S; Phillips KAM; Lix LM
    Health Promot Chronic Dis Prev Can; 2019 Jun; 39(6-7):216-224. PubMed ID: 31210047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends in prevalence of chronic disease and multimorbidity in Ontario, Canada.
    Steffler M; Li Y; Weir S; Shaikh S; Murtada F; Wright JG; Kantarevic J
    CMAJ; 2021 Feb; 193(8):E270-E277. PubMed ID: 33619067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Canadian Chronic Disease Surveillance System: A model for collaborative surveillance.
    Lix LM; Ayles J; Bartholomew S; Cooke CA; Ellison J; Emond V; Hamm NC; Hannah H; Jean S; LeBlanc S; O'Donnell S; Paterson JM; Pelletier C; Phillips KAM; Puchtinger R; Reimer K; Robitaille C; Smith M; Svenson LW; Tu K; VanTil LD; Waits S; Pelletier L
    Int J Popul Data Sci; 2018 Oct; 3(3):433. PubMed ID: 32935015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Examining early and late onset of multimorbidity in the Canadian Longitudinal Study on Aging.
    Nicholson K; Griffith LE; Sohel N; Raina P
    J Am Geriatr Soc; 2021 Jun; 69(6):1579-1591. PubMed ID: 33730382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the estimated prevalence of mood and/or anxiety disorders in Canada between self-report and administrative data.
    O'Donnell S; Vanderloo S; McRae L; Onysko J; Patten SB; Pelletier L
    Epidemiol Psychiatr Sci; 2016 Aug; 25(4):360-9. PubMed ID: 26081585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Report summary - Mood and Anxiety Disorders in Canada, 2016.
    McRae L; O'Donnell S; Loukine L; Rancourt N; Pelletier C
    Health Promot Chronic Dis Prev Can; 2016 Dec; 36(12):314-315. PubMed ID: 27977086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. At-a-glance - Twenty years of diabetes surveillance using the Canadian Chronic Disease Surveillance System.
    LeBlanc AG; Jun Gao Y; McRae L; Pelletier C
    Health Promot Chronic Dis Prev Can; 2019 Nov; 39(11):306-309. PubMed ID: 31729313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Social disparities in the prevalence of multimorbidity - A register-based population study.
    Schiøtz ML; Stockmarr A; Høst D; Glümer C; Frølich A
    BMC Public Health; 2017 May; 17(1):422. PubMed ID: 28486983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prevalence of multimorbidity and associations with lifestyle factors among middle-aged Canadians: an analysis of Canadian Longitudinal Study on Aging data.
    Sakib MN; Shooshtari S; St John P; Menec V
    BMC Public Health; 2019 Feb; 19(1):243. PubMed ID: 30819126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regional variation in self-reported heart disease prevalence in Canada.
    Chow CM; Donovan L; Manuel D; Johansen H; Tu JV;
    Can J Cardiol; 2005 Dec; 21(14):1265-71. PubMed ID: 16341294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence, characteristics, and patterns of patients with multimorbidity in primary care: a retrospective cohort analysis in Canada.
    Nicholson K; Terry AL; Fortin M; Williamson T; Bauer M; Thind A
    Br J Gen Pract; 2019 Sep; 69(686):e647-e656. PubMed ID: 31308002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Report Summary--Mental Illness in Canada, 2015.
    ; ; ;
    Health Promot Chronic Dis Prev Can; 2015 Aug; 35(6):95-6. PubMed ID: 26302228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns and temporal trends of comorbidity among adult patients with incident cardiovascular disease in the UK between 2000 and 2014: A population-based cohort study.
    Tran J; Norton R; Conrad N; Rahimian F; Canoy D; Nazarzadeh M; Rahimi K
    PLoS Med; 2018 Mar; 15(3):e1002513. PubMed ID: 29509757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Surveillance System to Monitor Excess Mortality of People With Mental Illness in Canada.
    Lesage A; Rochette L; Émond V; Pelletier É; St-Laurent D; Diallo FB; Kisely S
    Can J Psychiatry; 2015 Dec; 60(12):571-9. PubMed ID: 26720826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Report summary. Diabetes in Canada: facts and figures from a public health perspective.
    Pelletier C; Dai S; Roberts KC; Bienek A; Onysko J; Pelletier L
    Chronic Dis Inj Can; 2012 Dec; 33(1):53-4. PubMed ID: 23294922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends in obesity and multimorbidity in Canada.
    Lebenbaum M; Zaric GS; Thind A; Sarma S
    Prev Med; 2018 Nov; 116():173-179. PubMed ID: 30194961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multimorbidity prevalence and health outcome prediction: assessing the impact of lookback periods, disease count, and definition criteria in health administrative data at the population-based level.
    Simard M; Rahme E; Dubé M; Boiteau V; Talbot D; Sirois C
    BMC Med Res Methodol; 2024 May; 24(1):113. PubMed ID: 38755529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.